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Summary: 
A total of 25 isolates of Pseudomonas aeruginosa out of 80 samples isolated from various 
clinical sources (burns, wounds, urinary tract infections (UTIs),sputum and otitis media), 
From patients were attending to Hilla Teaching Hospital. 
Maximum isolates were obtained fromburn samples9(36%),wound and otitis media 
samples5(20%), UTIsandsputum3(12%). 
Some virulence factors of all isolates were studied, and the results showed that all bacterial 
isolates (100%) having bacteriocin, extracellular protease, lipase and urease enzyme, most the 
isolates (86.8%) being able to produce hemolysin, but some isolates (13.2%) producing the 
siderophores.  
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 Introduction: 
      The genus Pseudomonas is Gram-negative, rod-shaped bacterium, strict aerobic with 
unipolar motility, The genus Pseudomonas contains more than 140 species, most of which 
are saprophytic; more than 25 species of Pseudomonas are associated with humans(1).Most 
Pseudomonas known to cause disease in humans are associated with opportunistic infections 
especially Pseudomonas aeruginosa(2).It causes disease in individuals; it is a major threat to 
hospitalized and immunocompromised patients, particularly those with serious underlying 
diseases such as cancer and burns (3).The high motility associated with these infections is 
due to a combination of weakened host defense, bacterial resistance to antibiotics, and the 
production of extracellular bacterial enzymes and toxins (4).Pseudomonas aeruginosa is a 
pathogen that causes nosocomial infections, accounting for 20% of pneumonia and 16% of 
urinary tract infections according to recent data from national nosocomial surveillance system 
(5). The medical problem results from this organism are its ability to resist almost all 
antibacterial agents, leading to predominate over it when the sensitive organisms are 
suppressed by these agents (6). There are limited numbers of antimicrobial agents including 
the anti-pseudomonal Penicillins, Cephalosporin, Carbapenems, Aminoglycosides and 
Fluoroquinolons with reliable activity against its (7). Also the medically importance of this 
organism  may be lies in its ability to produce a variety of toxins, extracellular enzymes 
including elastases, proteases and hemolysins (8). 
 
 
Aims of the study  
1 - Isolation and identification of Pseudomonas aeruginosa from different clinical 
speciemens.  
2-Study some factors associated with pathogenecity of Pseudomonas aeruginosa such as 
haemolysin, sidrophore, bacteriocin, extracellular protease, lipase and urease. 
 
Material and methods 
Specimen and isolates: 
25 Ps. aeruginosa isolates out of 80 samples from different clinical sources. 
 
1-Detection of haemolysin production was achieved according to methods of (9). 
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2-Detection of sidrophore production was achieved according to methods of (10). 
3-Detection of bacteriocin production was achieved according to methods of (11). 
4-Detection of Protease production was achieved according to methods of (12). 
5-Detection of Lipase production was achieved according to methods of (13). 
6-Detection of Urease production was achieved according to methods of (13). 
 
Results and discussion 
In this study a total of (80) samples were obtained from patients suffering from burns, 
wounds, urinary tract infections (UTIs), throat infections and otitis media, Table(1) 
 
Table (1) Distribution of samples and number of Ps. aeruginosa isolates: 
% Number of Ps. 
aeruginosa isolates 
Total Number of sample Sample 
36 9 22 Burns 
20 5 13 wounds 
12 3 9 Urine 
12 3 12 sputum 
20 5 24 Otitis media 
100 25 80 Total 
 
In the present study, the distribution of Ps. aeruginosa isolates according to the site of 
infection was studied; it was found that the most infections of this bacterium occur in the 
burns (36%). This result resemble the result obtained by (14) who found that among the 
(1500) isolates of Ps. aeruginosa300(20.0%) isolates from burn infections, but the results 
were not agreed with the results obtained by (15) who found that among the 65 isolates of 
this bacterium 5(7.7%) burns were found.  
In the present study Ps. aeruginosa in wounds infection was studied it was found that 
infection with this bacterium in wounds less than the infection in burns (20%).  
This result was resemble with the result reported by (16) who found that Ps. aeruginosa 
present in wound infection in rate (15.84%). 
The result obtained in this study showed that five isolates (20%) of Ps. aeruginosa were 
isolated from patients with otitis media.(17) showed that the isolation percentage of Ps. 
aeruginosa was reached to (11%) if compared with other causative agents (aerobic and 
anaerobic bacteria) isolates from otitis media. 
Also, Urinary tract infection is one of the most common disease entities deal with by 
urologists, general practitioners, surgeon and all other members of the medical profession. 
The possible factors leading to UTI include pregnancy, diabetes mellitus, nephrolithiasis 
urological instrumentation, urinary tract abnormalities, burns, and vesico-urethral reflux (18).  
      The results of the present study showed only 3 isolates (12%) of Ps. aeruginosa were 
isolated from sputum samples. This result was acceptable with the result obtained by (19) 
who found that 55 isolates of Ps. aeruginosa(26.57%) can be isolated from sputum. but did 
not accept the result obtained by (20) who has succeeded to isolate Ps. aeruginosa from 
sputum at rate reaching (2.76%),  
In this study some virulence factors,(haemolysin, sidrophore, bacteriocin, extracellular 
protease, lipase and urease) were examined. Production of hemolysin by Ps. aeruginosa 
ismostly associated with pathogenic bacteria, therefore it is considered as important factor 
that participates in their pathogenesis (21). Hemolysin production by Ps. aeruginosa was 
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studied, it was found that (86.8%) isolates were able to produce extracellular hemolysin on 
blood agar,these results shown in Table (2). 
These results bring into line with (22) who demonstrated that (76%) of Ps. aeruginosa 
isolates that isolated from different clinical sources exhibit hemolysin on blood agar plates, 
but(23) found that (10%) strains produced hemolysin. 
. 
      Ps. aeruginosa has two pathways to take iron, one of these pathway is hemolysin, and 
these bacteria produce two hemolysins, it appear to be cytotoxic for most eukaryotic cells, 
hemolysins contribute to invasion through their cytotoxic effects on eukaryotic cells. Bacteria 
may use hemolysins as a way to obtain nutrients from host cells. For example, iron may be a 
limiting factor in the growth of various pathogenic bacteria (24). 
      Hemolysin is lytic to erythrocytes and it is toxic to a range of host cells in ways that 
probably contribute to inflammation, tissue injury, and impaired host defenses. Exposure of 
PMNLs and release of leukotriene and ATP; cause marked morphologic alterations; and 
impair chemotaxis and phagocytosis. Lysis occurs at higher concentrations (25.).  
In present study, Ps. aeruginosa isolates are also investigated for their ability to produce 
siderophores synthesis. The results show that (13.2%) isolates of Ps. aeruginosa are able to 
produce siderophores, these results shown in Table (2). 
The role of siderophores is to scavenge iron from the environment and to make the mineral, 
which is almost always essential, and available to the microbial cell. Most aerobic and 
facultative anaerobic microorganisms synthesize at least one type of siderophores. The 
microbes requires iron for variety of functions including the electron transport chain, in 
deoxyribonucleotide synthesis, in the synthesis of heme and for incorporation in the proteins 
involved in nitrogen fixation (26). 
      The isolates of Ps. aeruginosa appear hemolysis on the blood agar and do not have 
siderophores; these results resemble the result obtained by (27).  
      The bacteria that are able to produce siderophores have no ability to produce hemolysin, 
so that bacteria need only one mechanism for obtaining iron that can increase disease risk by 
functioning as a readily a viable essential nutrient for invading microbial and neoplastic cell, 
to survive and replicate in host, microbial pathogens must acquire host iron, that identical 
with the results obtained by (28). 
  All isolates (100%) in the present study produce bacteriocin when being tested with the 
sensitive gram negative indicator isolates like (E. coli, Klebsiella pneumonia, Proteus 
mirabilis).This result is agreed with the results obtained by (29) who pointed that (90%) of 
Ps. aeruginosa can produce bacteriocin.These results shown in Table (2). 
        (30) reported that (85%) of Ps. aeruginosa isolates were a producer of bacteriocin. 
 The antimicrobial protein produced by Pseudomonas aeruginosa that kill or inhibit the 
growth of other bacteria related to the same group or species (31). 
Bacteriocin directly or indirectly is associated with virulence because bacteriocin binds to 
receptors at the bacterial cell surface. The sensitivity of isolates to bacteriocin is dependent 
on the formation of specific receptors found on the outer surface of the cell. The producer 
strains present a self-protection mechanism. This bacteriocin is resistant to a wide range of 
pH, high temperatures and also to several proteolytic enzymes(32). 
The bacteriocin showed high activity of antibacterial action, mostof the bacteriocine exert 
their lethal activity by the adsorption to specific receptors in the external surface of the 
sensitive bacteria (31) and then they are able to interact with the cytoplasmic membrane 
leading to the bacterial death (33). 
 
Protease production by Ps. aeruginosa isolates was studied; it was found that all these 
isolates(100%) have this enzyme appears as a zone around the colony when being grown on 
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M9 media after adding of 3ml of 5% Trichloroacetic acid and incubation for 24 hrs. as shown 
in Table (2). 
Ps. aeruginosa could produce of large numbers of extracellular protease such as alkaline 
protease, elastase, and exotoxine A which can cleave IgA which then lead to inhibit the 
function of the cells of the immune system, thus Ps. aeruginosa is resistant to phagocytosis 
and opsonization (34). 
     Proteases play a crucial role in numerous pathologic processes, arthritis, tumor invasion 
and metastasis. The Infection and a number of degenerative diseases have been linked with 
the involvement of one or more proteolytic enzymes. The proteolytic activity has a maximum 
activity similar to other experiment of protease from microbial origin (35).  
The proteases proposed as virulence factors ina variety of diseases caused by this 
microorganism. The virulence of Pseudomonas aeruginosa is multifactorial, but it is partly 
determined by exo-products such as alkaline protease and elastase that are responsible for the 
damage of tissues by degrading elastin collagen and proteoglycans.These enzymes also 
shown to degrade proteinsthat function in host defense in vivo (36). 
Ability of Ps. aeruginosa to produce lipase has been investigated and found that all these 
isolates (100%) are able to produce lipase after incubation for 48 hrs. on egg yolk agar. These 
results shown in Table (2). 
This result was consistent with (37), who found that all isolates examined in their study gave 
positive result in a test for lipase production. Lipase is water-soluble enzyme that catalyzes 
the hydrolysis of ester chemical bonds in water insoluble lipid substrate, most lipases act as a 
specific position on the glycerol backbone of lipid substrate (38).  
      Two distinct lipase enzymes were produced by Ps. aeruginosa, PLC-N (non-hemolytic) 
and PLC-H (hemolytic), both enzymes are phosphate regulated. The two enzymes could work 
sequentially and synergistically to lyse host cells (39).  
      The lipase production can be arrested by various compounds such as Tetracycline which 
are effective against lipase production by interfering with protein synthesis by binding to 
bacterial ribosome (40). 
Urease production by Ps. aeruginosa isolates was studied, and found that all these isolates 
(100%) were able to produce urease, these result shown in Table (2). 
   The result of this study came in agreement with the result obtained by (41) who found that 
all isolates of Ps. aeruginosa were able to produce this enzyme. 
(42) found that ureases are enzymes widespread among organisms that hydrolyze urea into 
ammonia and carbon dioxide. Bacterial ureases are multimers of two or three subunit 
complexes. 
 Urease activity enables bacteria to use urea as the sole nitrogen source urease provided a 
suitable condition for bacterial survival in the site of infection through changing the pH and 













 Print ISSN: 2073-8854  &  Online ISSN: 2311-6544  



























1.Ryan, K. J. and Ray, C. G. (2004). Sherris Medical Microbiology 4
th
 ed. McGraw Hill. PP: 
222-227. 
2.Baron, E. J.; Jorgensen, J. H.; Pfaller, M. A. and Yolken,   R. H. (2003). ASM Manual of 
Clinical Microbiology 8
th 
ed. ASM Press, Washington. 
3.Iglewski, B. H. (1996). Pseudomonas. In: Baron s Medical Microbiology 4
th
ed. Univ. 
Texas.Medical Branch. PP: 122-132. 
4.Anzai, Y.; Kim, H. and Wakabayashi, H. (2000). Phylogenetic affiliation of the 
pseudomonas based on 16S rRNA sequence. Int. J. Syst. Evol. Microbiol. 50: 1563-1589. 
5.Worlitzsch, D.; Terran, R. and Ulrich, M. (2002). Effect of reduced mucus oxygen 
concentration in airway pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 
109(3): 317-325.  
6.Cunha, B. A. (2000). Antibiotic Resistance.Medical clinics ofNorth America.Antibiotic 
Therapy. 84(6):1407 – 1421. 
7.Cooper, M.; Tavankar, G. R. and Williams, H. D. (2003). Regulation of expression of the 
cyanid-insensetive terminal oxidase in Pseudomonas aeruginosa.Microbiol. 149 (5): 1275-
1284. 
8.Brooks, G. F.; Butel, J. S. and Morse, S. A. (2001). Jawetz, Melnik and Adel bergs.Medical 
Microbiology. 22nd ed.. Medical East ed. Appleton Large, PP:229-213. 
9.Baron, E. J.; Peterson, L. R. and Finegold, S. M. (1994). Bailey and Scott’s Diagnostic 
Microbiology. 9th ed., the C.V. Mosby Company, U.S.A 
10.Nassif, X. and Sansonetti, P. J. (1996). Correlation of the virulence of 
Klebsiellapneumoniae K1 and K2 with the presence of a plamid encoding aerobactin. Infect. 
Immune. 54(3): 603-608. 
11.AL-Qassab, A. O. and AL-khafaji Z. M. (1992). Effect of different conditions on 
inhibition activity of enteric Lactobacilli against diarrhea-causing enteric bacteria. J. Agric. 
Sci. 3(1): 18-26. 
12.Piret, J.; Millet, J. and Demain, A. (1993). Production of intracellular protease during 
sporulation of Bacillus brrevis. Eur. J. Appl. Microbiol. Biotechnol. 17: 227-230. 
13.Collee, J.G.; Fraser, A. G.; Marmion, B. P. and Simmons, A. (1996).  Mackie and 
Mecartney. Practical Medical Microbiology 
Virulence factors Total No.(%) 






 Print ISSN: 2073-8854  &  Online ISSN: 2311-6544  








14.Nadeem, S. G.;Qasmi, S. A.;Afaque, F.;Saleem, M. and Hakim , S. T. (2008). Comparison 
of the in vitro susceptibility of clinical isolates of Pseudomonas aeruginosa in a local hospital 
setting in Karachi, Pakistan.BJM. 2(4) 35-39. 
15.Vives-Flores, G. and Garnica, D. (2006). Comparison of virulence between clinical and 
environmental Pseudomonas aeruginosa isolates, Infect. Immun. 9: 247-252. 
16.Kluytmans, J. (1997). Surgical infections including burns. In: Wenzel RP. Prevention and 
control of nosocomial infections. 3
rd
 ed. Baltimore: Williams and Wilkins. PP: 841-865. 
17.AL-Amir, L. A. (1998). Molecular study of virulence factors in Ps. aeruginosa. Ph.D. 
Thesis, Baghdad University. 




19.Vazquez, F.; Mendoza, M. C.; Villar, M. H.; Vindel, A. and Mendez, F. J. C. (2002). 
Characteristics of Ps. aeruginosa strains causing septicemia in a Spanish hospital 1981-1990. 
Eur. J. Clin. Microbiol. Infect. Dis. 11(8): 698-703. 
20.Arancibia, F. MD; Torsten, T.; Bauer, MD; Santiago Ewig, MD; Josep Mensa, MD; Julia 
Gonzalez, MD;Michael S. Niederman, MD and Antoni Torres, MD. (2002). Community-
Acquired Pneumonia Due to Gram-Negative Bacteria and Pseudomonas aeruginosa. 162: 
1849-1858. 
21.Madigan, M. T.; Martinko, J. M. and Parker, J. (2007). Host-parasite relationships. In: 
Brock biology of microorganisms. Madigan M T, Martinko J M, Parker J, eds. Prentice Hall: 
Englewood Cliffs, N. J. PP: 785-812. 
22.Van Delden, C. V. and Iglewski, B. H. (2008).Cell – to – cell signaling and Ps. 
aeruginosa infections.Emerg.  Infect. Dis. 4. (1): 77-88. 
23.Aggarwal, N.; Kalra, M. S.; Singh, A. (2000). Pleiotropic changes in the activities of 
extracellular toxins of Ps. aeruginosa protease– deficient mutants. ActaMicrobiol Pol. 38(3-
4): 313-326. 
24.Sritharan, M. (2006). Iron and bacterial virulence.Indian. J. Med. Microbiol. 24 (3): 163–
164 
25.Gadeberg, O.V.; Orskov, I. and Rhodes, J.M.(2003).Cytotoxic effect of an alpha-
hemolytic Escherichia coli strain on human blood monocytes and granulocytes in vitro. 
Infect. Immune. PP: 337-341. 
26.Andrew, S. C. (1998). Iron Storage in bacteria. Adv. in MicrobiolPhysiol,40: 281 - 351.7 
27.Valvano, M. A.; Silver, R. P. and Crose, J. H. (2001). Occurencen of chromosome or 
plasmid mediated aerobacter in iron transport of human invasive strain of E. coli KI. Infect. 
Immune. 53(1): 192-199. 
28.Goel, U. K. and Kapil, A. (2001).Monoclonal antibodies against the iron regulated outer 
membrane proteins of Acinetobacterbaumanniiare bacteriocidal B.M.C. Microbiol.1: 16-20. 
29.Cherif, A.; Ouzari, H.;Daffonchio, D.;Cherif, H.;Ben Slama, K.; Hassen, A.;Jaoua, S. and 
Boudabous,A. (2001). Thuricin 7: A novel bacteriocin produced by Bacillus 
thuringiensisBMG1.7, a new strain isolated from soil. Lett. Appl. Microbiol. 32: 2432-2447. 
30.Dykes, G. (2005). Bacteriocins: ecological and evolutionary significance.Trends Ecol. 
Evol. 10: 186-189. 
31.Hubert, E.;Brevis, P.;Lobos O. and Padilla, C. (2008). Purification and characterization of 
the bacteriocin PsVP-10 produced by Pseudomonas sp. J. Appl. Microbiol. 84: 910-913. 
32.Brook, I. (1999). Bacterial interference. Crit. Rev. Microbiol. 25:155-172. 
33.Konisky, J. (2002). Colicins and other bacteriocins with established mode of action. Ann. 
Rev. Microbiol. 36: 125-144. 
34.Weber, K. and Osborn, M. (1992). The reliability of molecular weight determination by 
dodcyl sulfate-polyacrylamide Gel electrophoresis.Indian.Physical.Biochem. 6(4): 1223-
1230. 
 Print ISSN: 2073-8854  &  Online ISSN: 2311-6544  








35. Ferrero, M. A.; Castro, G. R.; Abate, C. M.; Baigori, M. D. and Sineriz, F. (1996) 
Thermostable alkaline proteases of Bacillus licheniformisMIR 29: isolation, production and 
characterization. Appl. Microbiol. Biotechnol. 45: 327-332. 
36. Sakata, Y.; Akaike, T.; Suga, M.; Ijiri, S.; Ando, M. and Maeda, H. (1996). Bradykinin 
generation triggered by Pseudomonas proteases facilitates invasion of the systemic 
circulation by Ps. aeruginosa. Microbiol.Immunol. 40(6): 415-442. 
37. Amara, A. A.;Salem S. R. and Shabeb,M. S. A. (2009). Biodetergent: The possibility to 
use bacterial protease and lipase as detergent,JMicrobiol 20(3):312-320 . 
38.Svendsen, A. (2000). Lipase protein enginerring.ActaBiochem.Biophys. 1543(2): 223-
228. 
39. Van Dyke, M. I.;Lee, H. and Trevors, J. T. (2001).Applications of microbial 
surfactants.Biotechnol.Adv. 9: 241-252. 
40. Stickler. D. J. and Zimakoff, S. (2004). Complication of UTI associated with devices for 
long-term bladder management. J. Hosp. Infect 28: 177-194. 
41.Jyothi, N. and Umamaheswar, R. V. (2009). Protease and urease production during 
utilization of diesel by fluorescent Pseudomonas species isolated from local soil. Iranin J. 
Microbiol.1(3): 23-30. 
42. Mclean, R. J.; Nickel, J. C.; Cheng, K. J. and Costerton, J. W. (1998). The ecology and 
pathogenicity of urease producing bacteria in the urinary tract.CRC Crit. Rev. Microbiol. 
16(1): 37-79.  
 
 
